Premium
Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti‐tumour necrosis factor alpha
Author(s) -
Marques E.,
Arenberger P.,
Smetanová A.,
Gkalpakiotis S.,
Zimová D.,
Arenbergerová M.
Publication year - 2021
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.19716
Subject(s) - hidradenitis suppurativa , medicine , alpha (finance) , tumor necrosis factor alpha , necrosis , dermatology , surgery , disease , patient satisfaction , construct validity
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom